Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 284-291 , September 2006

The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients

  • Wan Sub Shim

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Republic of Korea
    • ,
  • Hae Jin Kim

      Affiliations

    • Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Republic of Korea
    • ,
  • Eun Seok Kang

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Republic of Korea
    • ,
  • Chul Woo Ahn

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Republic of Korea
    • ,
  • Sung Kil Lim

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Republic of Korea
    • ,
  • Hyun Chul Lee

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Republic of Korea
    • ,
  • Bong Soo Cha

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Republic of Korea
    • Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Republic of Korea
    • Corresponding Author InformationCorresponding author at: Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong, Seodaemoon-Ku, Seoul 120-749, Republic of Korea. Tel.: +82 2 2228 1962; fax: +82 2 393 6884.

Received 23 November 2005 ,Accepted 2 February 2006.

References 

  1. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146
  2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998;339:229–234
  3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607
  4. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all causes: finding from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309–314
  5. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third national health and nutrition examination survey (NHANES III); Nationcal Cholesterol Education Program (NCEP): NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHENES III participants age 50 years and older. Diabetes. 2003;52:1210–1214
  6. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984–1992. Circulation. 1999;99:142–237
  7. Ross R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 1999;340:115–126
  8. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O’Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836–844
  9. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511
  10. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N. Engl. J. Med. 1974;290:1275–1278
  11. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA. 1992;267:1253–1256
  12. Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort. Am. J. Epidemiol. 1982;116:496–509
  13. Olivares R, Ducimetiere P, Claude JR. Monocyte count: a risk factor for coronary heart disease?. Am. J. Epidemiol. 1993;137:49–53
  14. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am. J. Epidemiol. 1997;145:416–421
  15. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486–2497.
  16. WHO. The Asia-Pacific perspective: refining obesity and its treatment. IOTF February 2000.
  17. Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diab. Care. 2004;27:216–222
  18. Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA. Association between hematological parameters and metabolic syndrome components in a Chinese population. J. Diab. Complicat. 2004;18:322–327
  19. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309–314
  20. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51:455–461
  21. Ohshita K, Yamane K, Hanafusa M, Mori H, Mito K, Okubo M, et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diab. Care. 2004;27:491–496
  22. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 1992;136:525–537
  23. Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J. Intern. Med. 1996;239:435–441
  24. Fernandez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia. 1999;42:1367–1374
  25. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997;82:4196–4200
  26. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab. 2001;86:1154–1159
  27. Sims E. Humoral Factors 1–373. Oxford: IRL Press; 1993;
  28. Festa A, D’Agostino R, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects: the Insulin Resistance Atherosclerosis Study. Diab. Med. 2002;19:939–943
  29. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol. 2002;39:1145–1150Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–2072
  30. Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, et al. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ. Res. 2003;92:371–377
  31. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J. Clin. Endocrinol. Metab. 2002;87:4602–4606
  32. Hansen K, Sickelmann F, Pietrowsky R, Fehm HL, Born J. Systemic immune changes following meal intake in humans. Am. J. Physiol. 1997;273:R548–R553
  33. van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J. Lipid. Res. 2003;44:576–583
  34. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diab. Care. 1998;21:360–367

PII: S0168-8227(06)00033-7

doi: 10.1016/j.diabres.2006.02.001

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 284-291 , September 2006

Article Tools